Public Employees Retirement System of Ohio Takes $3.12 Million Position in Baxter International Inc. $BAX

Key Points

• Public Employees Retirement System of Ohio acquired 146,455 Baxter International shares during the second quarter, a position valued at approximately $3.12 million. Institutional investors collectively own 90.19% of the company.
• Analysts remain broadly cautious, with two Buy, nine Hold, and two Sell ratings; the average price target is $22.45, below the stock’s reported $25.81 opening price.
• Baxter exceeded quarterly expectations with adjusted EPS of $0.56 versus the $0.37 consensus and revenue of $2.96 billion, up 5.3% year over year. The company also declared a quarterly dividend of $0.01 per share.

Public Employees Retirement System of Ohio acquired a new stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 146,455 shares of the medical instruments supplier's stock, valued at approximately $3,122,000.

Several other large investors have also added to or reduced their stakes in the stock. Imprint Wealth LLC purchased a new position in Baxter International during the 3rd quarter valued at about $27,000. Jones Financial Companies Lllp bought a new position in shares of Baxter International in the second quarter valued at approximately $26,000. Basepoint Wealth LLC purchased a new position in Baxter International during the fourth quarter valued at approximately $26,000. MUFG Securities EMEA plc bought a new stake in Baxter International during the 2nd quarter worth approximately $46,000. Finally, Los Angeles Capital Management LLC purchased a new stake in Baxter International in the 4th quarter worth approximately $46,000. Institutional investors own 90.19% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on BAX shares. Wells Fargo & Company raised their price target on shares of Baxter International from $19.00 to $23.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Weiss Ratings upgraded Baxter International from a "sell (d-)" rating to a "sell (d)" rating in a research report on Friday, July 31st. Zacks Research raised Baxter International from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 11th. The Goldman Sachs Group boosted their target price on Baxter International from $19.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. Finally, UBS Group upped their target price on Baxter International from $19.00 to $25.00 and gave the stock a "hold" rating in a research note on Tuesday, July 28th. Two investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $22.45.

Baxter International Stock Performance

Baxter International stock opened at $25.81 on Friday. Baxter International Inc. has a fifty-two week low of $15.73 and a fifty-two week high of $30.00. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The stock has a market cap of $13.34 billion, a P/E ratio of -12.47, a price-to-earnings-growth ratio of 3.87 and a beta of 0.60. The firm's fifty day moving average price is $24.73 and its 200-day moving average price is $20.72.

Baxter International (NYSE:BAX - Get Free Report) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.19. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm's quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities research analysts expect that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be given a dividend of $0.01 per share. The ex-dividend date is Friday, August 28th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International's dividend payout ratio is -1.93%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.